Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-07-21

FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Original Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

FDA approved the original application for budesonide and formoterol fumarate dihydrate (Symbicort) from AstraZeneca Pharmaceuticals LP, a combination inhaled co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Symbicort (budesonide/formoterol)

Snippet

ORIG AP for BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE (BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE)